US EditionPublished • loading... • Updated
Redefining the Role of GLP-1 Therapies: The Clinical Trials Behind the Expanding Indications
Summary by Pharmacy Times
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
GLP-1 Receptor Agonists Investigated for Heart Failure, Kidney Disease, and Neuroprotection Beyond Diabetes Management
Recent clinical trials have highlighted the expanding a […] The post GLP-1 Receptor Agonists Investigated for Heart Failure, Kidney Disease, and Neuroprotection Beyond Diabetes Management first appeared on GeneOnline News. The post GLP-1 Receptor Agonists Investigated for Heart Failure, Kidney Disease, and Neuroprotection Beyond Diabetes Management appeared first on GeneOnline News.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
